News Focus
News Focus
Followers 9
Posts 1084
Boards Moderated 0
Alias Born 11/25/2009

Re: stockfan100 post# 134375

Wednesday, 03/21/2018 10:10:24 PM

Wednesday, March 21, 2018 10:10:24 PM

Post# of 203937
At this stage, any therapy that uses allo- or autogeneic cells (meaning cells from the same (auto) or from a different individual but within the same species ... HUMAN that is (for most of us ;)) will be out of reach for most of us at this point in time. As I said before, this is personalized medicine and will only benefit the happy few who can afford paying half a million or more for treatment. Also, I cannot envisage any insurance willing to cover such costs.

In all, the technology is incredible powerful and especially with CAR-T or NK cells, we have seen some great results (> 80% or full remissions in specific cancers), but we are at least a decade away from seeing these applications becoming standard ... IF ever ... since technology seems to come up with alternatives that achieve the same efficiencies for a fraction of the cost ...

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y